Vipul Organics Limited, the BSE-listed speciality chemicals company in the pigments and dyes segment, has announced its audited financial results for the quarter and financial year ended 31 March 2026.

For FY 2025-26, total revenue stood at Rs 175.40 million on a standalone basis, up 7.74 per cent from Rs 162.80 million in FY 2024-25. Profit before tax (PBT) rose 50.24 per cent to Rs 9.55 million on a standalone basis, while consolidated PBT increased 50.44 per cent to Rs 9.53 million.

Profit after tax (PAT) grew 55.63 per cent to Rs 6.92 million on a standalone basis. Consolidated PAT stood at Rs 6.90 million, up 55.99 per cent. Earnings per share (EPS) expanded 41.70 per cent to Rs 3.84 on both standalone and consolidated bases, compared with Rs 2.71 standalone and Rs 2.70 consolidated in FY25.

The Board of Directors has recommended a dividend of 8 per cent, or Re 0.80 per equity share of face value Rs 10 each, for the financial year ended 31 March 2026. The dividend is subject to shareholder approval at the 54th Annual General Meeting.

On a quarter-on-quarter basis, total revenue for Q4 FY26 stood at Rs 52.62 million, up 13.47 per cent from Q3 FY26. PBT stood at Rs 3.01 million on a standalone basis, up 19.21 per cent from Q3 FY26. PAT stood at Rs 1.97 million on a standalone basis, up 6.30 per cent from Q3 FY26.

On a year-on-year basis, Q4 FY26 total revenue increased 19.67 per cent to Rs 52.62 million from Rs 43.98 million in Q4 FY25. Standalone PBT rose 155.60 per cent to Rs 3.01 million from Rs 1.18 million in Q4 FY25, while standalone PAT increased 148.59 per cent to Rs 1.97 million from Rs 0.79 million.

For FY 2025-26, standalone and consolidated total revenue stood at Rs 175.40 million, compared with Rs 162.80 million in FY 2024-25, reflecting 7.74 per cent growth. Standalone PBT stood at Rs 9.55 million, while consolidated PBT stood at Rs 9.53 million. Standalone PAT was Rs 6.92 million, while consolidated PAT was Rs 6.90 million. EPS stood at Rs 3.84 on both standalone and consolidated bases.

In Q4 FY26, standalone total revenue stood at Rs 52.62 million and consolidated total revenue at Rs 52.62 million, compared with Rs 46.38 million in Q3 FY26. Standalone PBT stood at Rs 3.01 million and consolidated PBT at Rs 3.01 million, compared with Rs 2.52 million and Rs 2.52 million, respectively, in Q3 FY26. Standalone PAT stood at Rs 1.97 million and consolidated PAT at Rs 1.97 million, compared with Rs 1.86 million and Rs 1.85 million, respectively, in Q3 FY26. EPS stood at Rs 1.10 on both standalone and consolidated bases in both quarters.

Compared with Q4 FY25, standalone and consolidated Q4 FY26 revenue grew 19.67 per cent. Standalone PBT rose 155.60 per cent, while consolidated PBT increased 158.25 per cent. Standalone PAT grew 148.59 per cent and consolidated PAT rose 152.35 per cent. EPS increased 129.17 per cent on a standalone basis and 134.04 per cent on a consolidated basis.

During the year, the company allotted 1.31 million shares of Rs 10 each at an issue price of Rs 211 each through preferential allotment on a private placement basis. EPS has been calculated using the weighted average method.

Vipul P Shah, Managing Director, Vipul Organics Limited, said, “FY 2025-26 has been a landmark year for Vipul Organics. Despite the headwinds posed by the ongoing conflict in the Middle East, which disrupted global shipping lanes and caused delays in certain export shipments, we have delivered our strongest financial performance to date, with PAT growing over 55 per cent and PBT over 50 per cent on a standalone basis. Within the country, our operations remained robust, and our cost optimisation initiatives continued to yield results. The Greenfield facility at Sayakha, Gujarat is progressing well, and we expect it to contribute to both capacity and revenue diversification in the coming year. With our expanded product mix, a growing global client base across 45+ countries, and improved operational efficiencies, we enter FY 2026-27 with confidence.”